SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-020411
Filing Date
2021-10-25
Accepted
2021-10-25 08:31:07
Documents
27
Period of Report
2021-10-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20211025.htm   iXBRL 8-K 39603
2 EX-99.1 aqst109investorupdatedec.htm EX-99.1 18821
3 EX-99.2 ex992_aqst109toplinedataoc.htm EX-99.2 57401
7 GRAPHIC aqst109investorupdatedec001.jpg GRAPHIC 70101
8 GRAPHIC aqst109investorupdatedec002.jpg GRAPHIC 256746
9 GRAPHIC aqst109investorupdatedec003.jpg GRAPHIC 105471
10 GRAPHIC aqst109investorupdatedec004.jpg GRAPHIC 124455
11 GRAPHIC aqst109investorupdatedec005.jpg GRAPHIC 114197
12 GRAPHIC aqst109investorupdatedec006.jpg GRAPHIC 92281
13 GRAPHIC aqst109investorupdatedec007.jpg GRAPHIC 126892
14 GRAPHIC aqst109investorupdatedec008.jpg GRAPHIC 89502
15 GRAPHIC aqst109investorupdatedec009.jpg GRAPHIC 107656
16 GRAPHIC aqst109investorupdatedec010.jpg GRAPHIC 100044
17 GRAPHIC aqst109investorupdatedec011.jpg GRAPHIC 93743
18 GRAPHIC aqst109investorupdatedec012.jpg GRAPHIC 103696
19 image_0.jpg GRAPHIC 62743
  Complete submission text file 0001628280-21-020411.txt   2272896

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20211025.xsd EX-101.SCH 1905
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20211025_lab.xml EX-101.LAB 24975
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20211025_pre.xml EX-101.PRE 13181
20 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20211025_htm.xml XML 11260
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 211342208
SIC: 2834 Pharmaceutical Preparations